Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

BUY
$194.33 - $283.97 $665,968 - $973,165
3,427 New
3,427 $682,000
Q1 2023

May 04, 2023

BUY
$175.41 - $217.92 $212,246 - $263,683
1,210 Added 35.07%
4,660 $1.01 Million
Q4 2022

Jan 31, 2023

SELL
$204.38 - $296.82 $183,942 - $267,138
-900 Reduced 20.69%
3,450 $709,000
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $105,413 - $167,686
-540 Reduced 11.04%
4,350 $1.21 Million
Q2 2022

Aug 23, 2022

BUY
$115.91 - $214.48 $10,084 - $18,659
87 Added 1.81%
4,890 $935,000
Q1 2022

Apr 29, 2022

BUY
$127.96 - $207.36 $13,179 - $21,358
103 Added 2.19%
4,803 $996,000
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $776,111 - $1.14 Million
4,700 New
4,700 $838,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.